Department of Nutrition, Food Science, and Physiology and Center for Nutrition Research, University of Navarra, Pamplona, Spain.
Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
Adv Nutr. 2019 Jan 1;10(suppl_1):S17-S30. doi: 10.1093/advances/nmy078.
Diverse evidence suggests that the gut microbiota is involved in the development of obesity and associated comorbidities. It has been reported that the composition of the gut microbiota differs in obese and lean subjects, suggesting that microbiota dysbiosis can contribute to changes in body weight. However, the mechanisms by which the gut microbiota participates in energy homeostasis are unclear. Gut microbiota can be modulated positively or negatively by different lifestyle and dietary factors. Interestingly, complex interactions between genetic background, gut microbiota, and diet have also been reported concerning the risk of developing obesity and metabolic syndrome features. Moreover, microbial metabolites can induce epigenetic modifications (i.e., changes in DNA methylation and micro-RNA expression), with potential implications for health status and susceptibility to obesity. Also, microbial products, such as short-chain fatty acids or membrane proteins, may affect host metabolism by regulating appetite, lipogenesis, gluconeogenesis, inflammation, and other functions. Metabolomic approaches are being used to identify new postbiotics with biological activity in the host, allowing discovery of new targets and tools for incorporation into personalized therapies. This review summarizes the current understanding of the relations between the human gut microbiota and the onset and development of obesity. These scientific insights are paving the way to understanding the complex relation between obesity and microbiota. Among novel approaches, prebiotics, probiotics, postbiotics, and fecal microbiome transplantation could be useful to restore gut dysbiosis.
有大量证据表明,肠道微生物群与肥胖及其相关并发症的发生有关。有报道称,肥胖和非肥胖人群的肠道微生物群组成存在差异,这表明微生物群失调可能导致体重变化。然而,肠道微生物群参与能量平衡的机制尚不清楚。不同的生活方式和饮食因素可以积极或消极地调节肠道微生物群。有趣的是,遗传背景、肠道微生物群和饮食之间的复杂相互作用也与肥胖和代谢综合征特征的发病风险有关。此外,微生物代谢产物可以诱导表观遗传修饰(即 DNA 甲基化和 micro-RNA 表达的变化),这可能对健康状况和肥胖易感性产生影响。此外,微生物产物,如短链脂肪酸或膜蛋白,可能通过调节食欲、脂肪生成、糖异生、炎症和其他功能来影响宿主代谢。代谢组学方法正被用于鉴定宿主中具有生物活性的新型后生元,从而发现新的靶点和工具,纳入个性化治疗。本综述总结了目前对人类肠道微生物群与肥胖的发生和发展之间关系的认识。这些科学见解为理解肥胖与微生物群之间的复杂关系铺平了道路。在新方法中,益生元、益生菌、后生元和粪便微生物群移植可以用来恢复肠道菌群失调。